EP0531026 - Hexahydrobenzo[f]quinolinones as 5-alpha-reductase inhibitors [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 24.09.1999 Database last updated on 04.06.2024 | Most recent event Tooltip | 24.09.1999 | No opposition filed within time limit | published on 10.11.1999 [1999/45] | Applicant(s) | For all designated states ELI LILLY AND COMPANY Lilly Corporate Center Indianapolis, IN 46285 / US | [N/P] |
Former [1993/10] | For all designated states ELI LILLY AND COMPANY Lilly Corporate Center Indianapolis, Indiana 46285 / US | Inventor(s) | 01 /
Hirsch, Kenneth Steven 6473 Haviland Mill Road Clarksville, Maryland 21029 / US | 02 /
Jones, Charles David 223 East Brunswick Avenue Indianapolis, Indiana 46227 / US | [1993/10] | Representative(s) | Tapping, Kenneth George, et al Lilly Industries Limited European Patent Operations Erl Wood Manor Windlesham Surrey GU20 6PH / GB | [N/P] |
Former [1993/10] | Tapping, Kenneth George, et al Lilly Industries Limited European Patent Operations Erl Wood Manor Windlesham Surrey GU20 6PH / GB | Application number, filing date | 92307636.8 | 20.08.1992 | [1993/10] | Priority number, date | US19910748134 | 21.08.1991 Original published format: US 748134 | US19910780166 | 21.10.1991 Original published format: US 780166 | [1993/10] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP0531026 | Date: | 10.03.1993 | Language: | EN | [1993/10] | Type: | B1 Patent specification | No.: | EP0531026 | Date: | 18.11.1998 | Language: | EN | [1998/47] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 21.01.1993 | Classification | IPC: | C07D221/10, A61K31/435 | [1993/10] | CPC: |
C07D221/10 (EP,US);
C07D215/06 (KR);
A61P43/00 (EP)
| Designated contracting states | DE, FR, GB, IT [1998/50] |
Former [1993/10] | AT, BE, CH, DE, DK, FR, GB, IE, IT, LI, LU, NL, PT, SE | Title | German: | Hexahydrobenzo(f)quinolinone als 5-alpha-reduktase Inhibitoren | [1993/10] | English: | Hexahydrobenzo[f]quinolinones as 5-alpha-reductase inhibitors | [1993/10] | French: | Hexahydrobenzo(f)quinolinones comme inhibiteurs de 5-alpha-réductase | [1993/10] | Examination procedure | 20.08.1992 | Examination requested [1993/10] | 17.01.1997 | Despatch of a communication from the examining division (Time limit: M06) | 16.06.1997 | Reply to a communication from the examining division | 03.02.1998 | Despatch of communication of intention to grant (Approval: Yes) | 03.04.1998 | Communication of intention to grant the patent | 15.06.1998 | Fee for grant paid | 13.08.1998 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time | 05.09.1998 | Fee for publishing/printing paid | Opposition(s) | 19.08.1999 | No opposition filed within time limit [1999/45] | Request for further processing for: | 05.09.1998 | Request for further processing filed | 05.09.1998 | Full payment received (date of receipt of payment) Request granted | 21.09.1998 | Decision despatched | Fees paid | Renewal fee | 05.07.1994 | Renewal fee patent year 03 | 07.07.1995 | Renewal fee patent year 04 | 26.07.1996 | Renewal fee patent year 05 | 21.07.1997 | Renewal fee patent year 06 | 04.07.1998 | Renewal fee patent year 07 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [AD]EP0102046 (SCHERING CORP [US]); | [AD]EP0230967 (HOFFMANN LA ROCHE [CH]); | [AD]GB2207135 (HOFFMANN LA ROCHE) |